Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy
通过 MUSE 进行癌症组织学和质量控制:保留样品的紫外表面激发显微镜
基本信息
- 批准号:9233713
- 负责人:
- 金额:$ 37.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-08 至 2020-02-28
- 项目状态:已结题
- 来源:
- 关键词:AppearanceAreaBasic ScienceBiologicalBiological AssayBiopsyBiopsy SpecimenCancer HistologyCell SurvivalCellsClinicClinicalColorComputer softwareContrast MediaDNADetectionDevelopmentDiagnosticDiseaseDyesEffectivenessEnsureEosine YellowishEpithelialExperimental Animal ModelExposure toFluorescenceFluorescent DyesFormalinFrequenciesFresh TissueGeometryGoalsHarvestHistologyImageImaging DeviceLabelLasersLesionManualsMethodsMicroscopeMicroscopyMicrotomyMolecularMolecular AnalysisMorphologic artifactsNervous System NeoplasmsOptical Coherence TomographyOpticsOrganParaffin EmbeddingPathologistPathologyPatientsPenetrationPreparationProcessProteinsRNAResearch PersonnelResolutionSamplingServicesSignal TransductionSlideSourceSpecimenStaining methodStainsSurfaceTestingTimeTissue SampleTissue ViabilityTissuesToxicologyTranslational ResearchUltrasonographyUltraviolet RaysValidationVisible RadiationXenograft procedurebasebiobankcancer diagnosiscostfile formathigh resolution imagingimaging capabilitiesinstrumentationlensnovelpoint of caresample fixationsoftware developmenttissue processingtooltumorvalidation studies
项目摘要
PROJECT SUMMARY: Pathology—determining the causes and effects of disease, often by using a
microscope to examine patients' tissue—is essential for arriving at a correct cancer diagnosis, but it has
become increasingly important to submit relevant portions of often tiny tissue samples for DNA and other
molecular and functional tests. Making sure that the submitted material actually contains tumor, in sufficient
quantity, is not always easy, and sometimes just preparing conventional microscope slides can consume most
or even the entire specimen. We have developed a new, simple and inexpensive approach we term MUSE, for
Microscopy with UV Surface Excitation, that can provide high-resolution images directly and quickly from fresh
tissue without consuming it, and thus can preserve intact, high-quality specimens for biobanking, downstream
molecular and functional analyses.
MUSE, by ensuring that acquired small biopsy specimens are indeed fit for purpose, can avoid the
need to have a patient return at a later date for additional biopsies. In addition, the method will allow for lesion
detection over larger cross-sections of tissue, such as organ whole-mounts, not currently practical with
conventional instrumentation. Finally, we expect that MUSE will yield additional biologically informative imaging
by avoiding artifacts inherent in conventional tissue processing and sectioning. We focus here on facilitation of
tissue-based molecular studies, viable tumor harvest for xenografts and cultured spheroids, and biobanking,
and include crucial validation studies to ensure that the MUSE process does not compromise sample utility due
to possible impacts from exposure to intercalating dyes and/or UV light.
MUSE relies on two mechanisms: 1) surface-restricted excitation of fluorescent dyes due to micron-
scale penetration of sub-300-nm ultraviolet light; and 2) the fact that many conventional dyes excited in this
way emit visible light. These signals are bright enough to be detected by conventional color cameras using
sub-second exposure times, allowing rapid imaging of large areas.
MUSE eliminates any requirement for conventional histology processing with formalin fixation, paraffin
embedding, or thin-sectioning. It requires no lasers, confocal, multiphoton or optical coherence tomography
instrumentation, can eventually cost in the range of a few thousands of dollars, and therefore affordable at the
point of care (point of biopsy). MUSE samples are stained within seconds using familiar histology stains, such
as eosin and DAPI, and the resulting high-resolution images converted from fluorescence to H&E-like
brightfield appearance for interpretation in real time (but with novel and potentially useful features) easily
interpreted by pathologists.
While rapid cellular-scale imaging of fresh tissue can have significant benefits in clinical arenas, it can
also empower basic and translational research use for essentially instant histology-, pathology- or
toxicology-relevant images directly from experimental animal models—at the bench—and may help relieve
such investigators from having to rely on often overworked, sometimes unavailable, conventional histology and
pathology services.
项目摘要:病理学 - 确定疾病的原因和影响,通常是通过使用
显微镜检查患者的组织 - 对于到达正确的癌症诊断至关重要,但它具有
提交通常微小的组织样本的DNA和其他相关部分变得越来越重要
分子和功能测试。确保提交的材料实际上包含肿瘤,足够
数量,并不总是那么容易,有时只是准备常规显微镜幻灯片可能会消耗大多数
甚至整个标本。我们已经开发了一种新的,简单且廉价的方法,我们称为缪斯女神
带有紫外表面激发的显微镜,可以直接从新鲜提供高分辨率图像
组织不食用它,因此可以保留完整的高质量标本,用于生物群,下游
分子和功能分析。
缪斯,通过确保获得的小型活检标本确实适合目的,可以避免
需要让患者在以后返回其他活检。此外,该方法将允许病变
检测较大的组织的横截面,例如器官的整数,目前不实用
常规仪器。最后,我们预计缪斯将产生更多的生物学内容丰富的成像
通过避免传统组织加工和切片固有的伪影。我们在这里专注于
基于组织的分子研究,用于异种移植物和培养的球类动物的可行肿瘤收获以及生物群,
并包括关键的验证研究,以确保缪斯过程不会损害样本实用程序
暴露于互化染料和/或紫外线的可能影响。
缪斯依赖于两种机制:1)由于微米而引起的荧光染料的表面限制兴奋
低300 nm紫外线的尺度渗透; 2)许多传统染料对此感到兴奋的事实
方式发出可见光。这些信号足够明亮,可以通过使用常规彩色摄像机检测到
次要暴露时间,可以快速成像大面积。
缪斯消除了使用福尔马林固定的传统组织学处理的任何要求,石蜡
嵌入或薄色。它不需要激光,共聚焦,多光子或光学相干断层扫描
仪器有时会花费数千美元的价格,因此在
护理点(活检点)。缪斯样品在几秒钟内使用熟悉的组织学污渍染色,例如
作为曙红和DAPI,以及所得的高分辨率图像从荧光转换为H&E样图像
Brightfield出现实时解释(但具有新颖且潜在有用的功能)很容易
由病理学家解释。
虽然新鲜组织的快速细胞尺度成像在临床领域可以具有显着好处,但可以
还赋予基本和翻译的研究用途,用于本质上是组织学 - 病理学或
直接来自实验动物模型的与毒理学相关的图像(在长凳上),并可能有助于营救
这样的研究人员不得不依靠经常劳累过度,有时不可用的传统组织学和
病理服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD M. LEVENSON其他文献
RICHARD M. LEVENSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD M. LEVENSON', 18)}}的其他基金
Breast core-needle diagnostics in LMICs via millifluidics and direct-to-digital imaging: development and validation in Ghana
通过微流体和直接数字成像对中低收入国家进行乳腺空心针诊断:在加纳进行开发和验证
- 批准号:
10416550 - 财政年份:2023
- 资助金额:
$ 37.36万 - 项目类别:
IMAT-ITCR Collaboration: Combining FIBI and topological data analysis: Synergistic approaches for tumor structural microenvironment exploration
IMAT-ITCR 合作:结合 FIBI 和拓扑数据分析:肿瘤结构微环境探索的协同方法
- 批准号:
10885376 - 财政年份:2023
- 资助金额:
$ 37.36万 - 项目类别:
CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies.
CoreView 和 FIBI 用于对核针乳腺活检进行快速现场评估和分子分析。
- 批准号:
10613211 - 财政年份:2023
- 资助金额:
$ 37.36万 - 项目类别:
3D Microscopy with Ultraviolet Surface Excitation (3D-MUSE)
紫外表面激发 3D 显微镜 (3D-MUSE)
- 批准号:
10620103 - 财政年份:2019
- 资助金额:
$ 37.36万 - 项目类别:
Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy
通过 MUSE 进行癌症组织学和质量控制:保留样品的紫外表面激发显微镜
- 批准号:
9901047 - 财政年份:2017
- 资助金额:
$ 37.36万 - 项目类别:
Imaging and informatics techniques to spatially map tumor-associated collagen: novel cancer diagnostic tools (2 of 2)
用于空间绘制肿瘤相关胶原蛋白的成像和信息学技术:新型癌症诊断工具(2 / 2)
- 批准号:
9613725 - 财政年份:2017
- 资助金额:
$ 37.36万 - 项目类别:
In-vivo optical molecular imaging with Dynamic Contrast Enhancement (DyCE)
动态对比度增强 (DyCE) 体内光学分子成像
- 批准号:
7485551 - 财政年份:2008
- 资助金额:
$ 37.36万 - 项目类别:
Spectrally resolved tomographic small-animal fluorescence imager
光谱分辨断层小动物荧光成像仪
- 批准号:
7223351 - 财政年份:2007
- 资助金额:
$ 37.36万 - 项目类别:
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
通过光谱成像进行活检中细胞解析的分子途径评估
- 批准号:
7754755 - 财政年份:2007
- 资助金额:
$ 37.36万 - 项目类别:
Cellularly resolved molecular pathway assessment in biopsies via spectral imaging
通过光谱成像进行活检中的细胞解析分子途径评估
- 批准号:
7298872 - 财政年份:2007
- 资助金额:
$ 37.36万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Identification of Trichomonas vaginalis resistance targets to inform future drug development
确定阴道毛滴虫耐药靶标,为未来药物开发提供信息
- 批准号:
10462312 - 财政年份:2023
- 资助金额:
$ 37.36万 - 项目类别:
One session treatment for dental phobia in an underserved population
服务欠缺人群的牙科恐惧症的一次疗程治疗
- 批准号:
10348505 - 财政年份:2022
- 资助金额:
$ 37.36万 - 项目类别:
HDO Imaging is a Quantitative Marker of Cerebral Glucose Oxidation
HDO 成像是脑葡萄糖氧化的定量标志物
- 批准号:
10687186 - 财政年份:2022
- 资助金额:
$ 37.36万 - 项目类别:
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease
阿尔茨海默病小鼠模型中前驱期突触、回路和网络水平功能障碍的多模态成像
- 批准号:
10562876 - 财政年份:2022
- 资助金额:
$ 37.36万 - 项目类别:
2022 International Congress on Integrative Medicine and Health
2022 年国际中西医结合医学与健康大会
- 批准号:
10468376 - 财政年份:2022
- 资助金额:
$ 37.36万 - 项目类别: